Cargando…

Mitophagy Protects the Retina Against Anti-Vascular Endothelial Growth Factor Therapy-Driven Hypoxia via Hypoxia-Inducible Factor-1α Signaling

Anti-VEGF drugs are first-line treatments for retinal neovascular diseases, but these anti-angiogenic agents may also aggravate retinal damage by inducing hypoxia. Mitophagy can protect against hypoxia by maintaining mitochondrial quality, thereby sustaining metabolic homeostasis and reducing reacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Yimeng, Wen, Feng, Yan, Chun, Su, Lishi, Luo, Jiawen, Chi, Wei, Zhang, Shaochong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591297/
https://www.ncbi.nlm.nih.gov/pubmed/34790659
http://dx.doi.org/10.3389/fcell.2021.727822
_version_ 1784599197468590080
author Sun, Yimeng
Wen, Feng
Yan, Chun
Su, Lishi
Luo, Jiawen
Chi, Wei
Zhang, Shaochong
author_facet Sun, Yimeng
Wen, Feng
Yan, Chun
Su, Lishi
Luo, Jiawen
Chi, Wei
Zhang, Shaochong
author_sort Sun, Yimeng
collection PubMed
description Anti-VEGF drugs are first-line treatments for retinal neovascular diseases, but these anti-angiogenic agents may also aggravate retinal damage by inducing hypoxia. Mitophagy can protect against hypoxia by maintaining mitochondrial quality, thereby sustaining metabolic homeostasis and reducing reactive oxygen species (ROS) generation. Here we report that the anti-VEGF agent bevacizumab upregulated the hypoxic cell marker HIF-1α in photoreceptors, Müller cells, and vascular endothelial cells of oxygen-induced retinopathy (OIR) model mice, as well as in hypoxic cultured 661W photoreceptors, MIO-MI Müller cells, and human vascular endothelial cells. Bevacizumab also increased expression of mitophagy-related proteins, and mitophagosome formation both in vivo and in vitro, but did not influence cellular ROS production or apoptosis rate. The HIF-1α inhibitor LW6 blocked mitophagy, augmented ROS production, and triggered apoptosis. Induction of HIF-1α and mitophagy were associated with upregulation of BCL2/adenovirus E1B 19-kDa protein-interacting protein 3 (BNIP3) and FUN14 domain containing 1 (FUNDC1), and overexpression of these proteins in culture reversed the effects of HIF-1α inhibition. These findings suggest that bevacizumab does induce retinal hypoxia, but that concomitant activation of the HIF-1α-BNIP3/FUNDC1 signaling pathway also induces mitophagy, which can mitigate the deleterious effects by reducing oxidative stress secondary. Promoting HIF-1α-BNIP3/FUNDC1-mediated mitophagy may enhance the safety of anti-VEGF therapy for retinal neovascular diseases and indicate new explanation and possible new target of the anti-VEGF therapy with suboptimal effect.
format Online
Article
Text
id pubmed-8591297
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-85912972021-11-16 Mitophagy Protects the Retina Against Anti-Vascular Endothelial Growth Factor Therapy-Driven Hypoxia via Hypoxia-Inducible Factor-1α Signaling Sun, Yimeng Wen, Feng Yan, Chun Su, Lishi Luo, Jiawen Chi, Wei Zhang, Shaochong Front Cell Dev Biol Cell and Developmental Biology Anti-VEGF drugs are first-line treatments for retinal neovascular diseases, but these anti-angiogenic agents may also aggravate retinal damage by inducing hypoxia. Mitophagy can protect against hypoxia by maintaining mitochondrial quality, thereby sustaining metabolic homeostasis and reducing reactive oxygen species (ROS) generation. Here we report that the anti-VEGF agent bevacizumab upregulated the hypoxic cell marker HIF-1α in photoreceptors, Müller cells, and vascular endothelial cells of oxygen-induced retinopathy (OIR) model mice, as well as in hypoxic cultured 661W photoreceptors, MIO-MI Müller cells, and human vascular endothelial cells. Bevacizumab also increased expression of mitophagy-related proteins, and mitophagosome formation both in vivo and in vitro, but did not influence cellular ROS production or apoptosis rate. The HIF-1α inhibitor LW6 blocked mitophagy, augmented ROS production, and triggered apoptosis. Induction of HIF-1α and mitophagy were associated with upregulation of BCL2/adenovirus E1B 19-kDa protein-interacting protein 3 (BNIP3) and FUN14 domain containing 1 (FUNDC1), and overexpression of these proteins in culture reversed the effects of HIF-1α inhibition. These findings suggest that bevacizumab does induce retinal hypoxia, but that concomitant activation of the HIF-1α-BNIP3/FUNDC1 signaling pathway also induces mitophagy, which can mitigate the deleterious effects by reducing oxidative stress secondary. Promoting HIF-1α-BNIP3/FUNDC1-mediated mitophagy may enhance the safety of anti-VEGF therapy for retinal neovascular diseases and indicate new explanation and possible new target of the anti-VEGF therapy with suboptimal effect. Frontiers Media S.A. 2021-11-01 /pmc/articles/PMC8591297/ /pubmed/34790659 http://dx.doi.org/10.3389/fcell.2021.727822 Text en Copyright © 2021 Sun, Wen, Yan, Su, Luo, Chi and Zhang. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cell and Developmental Biology
Sun, Yimeng
Wen, Feng
Yan, Chun
Su, Lishi
Luo, Jiawen
Chi, Wei
Zhang, Shaochong
Mitophagy Protects the Retina Against Anti-Vascular Endothelial Growth Factor Therapy-Driven Hypoxia via Hypoxia-Inducible Factor-1α Signaling
title Mitophagy Protects the Retina Against Anti-Vascular Endothelial Growth Factor Therapy-Driven Hypoxia via Hypoxia-Inducible Factor-1α Signaling
title_full Mitophagy Protects the Retina Against Anti-Vascular Endothelial Growth Factor Therapy-Driven Hypoxia via Hypoxia-Inducible Factor-1α Signaling
title_fullStr Mitophagy Protects the Retina Against Anti-Vascular Endothelial Growth Factor Therapy-Driven Hypoxia via Hypoxia-Inducible Factor-1α Signaling
title_full_unstemmed Mitophagy Protects the Retina Against Anti-Vascular Endothelial Growth Factor Therapy-Driven Hypoxia via Hypoxia-Inducible Factor-1α Signaling
title_short Mitophagy Protects the Retina Against Anti-Vascular Endothelial Growth Factor Therapy-Driven Hypoxia via Hypoxia-Inducible Factor-1α Signaling
title_sort mitophagy protects the retina against anti-vascular endothelial growth factor therapy-driven hypoxia via hypoxia-inducible factor-1α signaling
topic Cell and Developmental Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591297/
https://www.ncbi.nlm.nih.gov/pubmed/34790659
http://dx.doi.org/10.3389/fcell.2021.727822
work_keys_str_mv AT sunyimeng mitophagyprotectstheretinaagainstantivascularendothelialgrowthfactortherapydrivenhypoxiaviahypoxiainduciblefactor1asignaling
AT wenfeng mitophagyprotectstheretinaagainstantivascularendothelialgrowthfactortherapydrivenhypoxiaviahypoxiainduciblefactor1asignaling
AT yanchun mitophagyprotectstheretinaagainstantivascularendothelialgrowthfactortherapydrivenhypoxiaviahypoxiainduciblefactor1asignaling
AT sulishi mitophagyprotectstheretinaagainstantivascularendothelialgrowthfactortherapydrivenhypoxiaviahypoxiainduciblefactor1asignaling
AT luojiawen mitophagyprotectstheretinaagainstantivascularendothelialgrowthfactortherapydrivenhypoxiaviahypoxiainduciblefactor1asignaling
AT chiwei mitophagyprotectstheretinaagainstantivascularendothelialgrowthfactortherapydrivenhypoxiaviahypoxiainduciblefactor1asignaling
AT zhangshaochong mitophagyprotectstheretinaagainstantivascularendothelialgrowthfactortherapydrivenhypoxiaviahypoxiainduciblefactor1asignaling